一种新型全自动基于MRI的深度学习方法用于脑胶质瘤IDH突变状态分类
本研究利用癌症影像档案和癌症基因组图谱中214例受试者的多参数脑MRI及基因组信息,开发了仅用T2加权图像的T2-net和多对比度TS-net两种深度学习网络进行IDH分类和肿瘤分割。T2-net交叉验证准确率97.14%±0.04,TS-net为97.12%±0.09,仅用T2加权图像即可实现高准确度IDH分类。
要点
- T2-net仅用T2加权图像预测IDH突变状态,交叉验证准确率97.14%±0.04,AUC 0.98±0.01。
- TS-net多对比度网络交叉验证准确率97.12%±0.09,AUC 0.99±0.01。
- 全肿瘤分割Dice评分T2-net为0.85±0.009,TS-net为0.89±0.006。
核心结论
- 仅使用T2加权MR图像即可实现高准确度的IDH分类,作者认为这是迈向临床转化的重要里程碑。
研究设计与样本
- 从癌症影像档案和癌症基因组图谱获取214例受试者(94例IDH突变型,120例IDH野生型)的多参数脑MRI数据及对应基因组信息。
- 开发了仅用T2加权图像的T2-net和多对比度(T2加权、液体衰减反转恢复、T1增强)的TS-net两种网络,使用3D Dense-UNets训练,进行三折交叉验证。
- 采用受试者工作特征分析和Dice评分评估分类与肿瘤分割性能。
主要发现
- T2-net预测IDH突变状态的平均交叉验证准确率为97.14%±0.04,敏感度0.97±0.03,特异度0.98±0.01,AUC为0.98±0.01。
- TS-net的平均交叉验证准确率为97.12%±0.09,敏感度0.98±0.02,特异度0.97±0.001,AUC为0.99±0.01。
- 全肿瘤分割平均Dice评分T2-net为0.85±0.009,TS-net为0.89±0.006。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Isocitrate dehydrogenase (IDH) mutation status has emerged as an important prognostic marker in gliomas. Currently, reliable IDH mutation determination requires invasive surgical procedures. The purpose of this study was to develop a highly accurate, MRI-based, voxelwise deep-learning IDH classification network using T2-weighted (T2w) MR images and compare its performance to a multicontrast network. METHODS: Multiparametric brain MRI data and corresponding genomic information were obtained for 214 subjects (94 IDH-mutated, 120 IDH wild-type) from The Cancer Imaging Archive and The Cancer Genome Atlas. Two separate networks were developed, including a T2w image-only network (T2-net) and a multicontrast (T2w, fluid attenuated inversion recovery, and T1 postcontrast) network (TS-net) to perform IDH classification and simultaneous single label tumor segmentation. The networks were trained using 3D Dense-UNets. Three-fold cross-validation was performed to generalize the networks' performance. Receiver operating characteristic analysis was also performed. Dice scores were computed to determine tumor segmentation accuracy. RESULTS: T2-net demonstrated a mean cross-validation accuracy of 97.14% ± 0.04 in predicting IDH mutation status, with a sensitivity of 0.97 ± 0.03, specificity of 0.98 ± 0.01, and an area under the curve (AUC) of 0.98 ± 0.01. TS-net achieved a mean cross-validation accuracy of 97.12% ± 0.09, with a sensitivity of 0.98 ± 0.02, specificity of 0.97 ± 0.001, and an AUC of 0.99 ± 0.01. The mean whole tumor segmentation Dice scores were 0.85 ± 0.009 for T2-net and 0.89 ± 0.006 for TS-net. CONCLUSION: We demonstrate high IDH classification accuracy using only T2-weighted MR images. This represents an important milestone toward clinical translation.
引用
- Bangalore Yogananda CG, Shah BR, Vejdani-Jahromi M, et al. A novel fully automated MRI-based deep-learning method for classification of IDH mutation status in brain gliomas. Neuro Oncol. 2020. PMID: 31637430. doi:10.1093/neuonc/noz199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。